1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Merck Ophthalmics

Discussion in 'Ophthalmology' started by Anonymous, Feb 28, 2007 at 5:30 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    What's this I hear that Merck is going to try this experiment one more time? Are they crazy? 3times and your out!